P3 Health Partners (PIII) Proxy filing summary

Executive summary

• The annual meeting will be held virtually on June 9, 2026, with stockholders able to participate and vote online using a unique control number.

• Holders of Class A and Class V common stock as of April 10, 2026, are entitled to vote, with each share carrying one vote on all matters.

• The proxy statement and 2025 Annual Report are available online, and stockholders are encouraged to vote by phone, internet, or mail.

Voting matters and shareholder proposals

• Four main proposals: election of three Class II directors, ratification of BDO USA, P.C. as auditor, advisory approval of executive compensation, and approval of issuance of up to 3,341,130 shares of Class A common stock upon exercise of warrants held by VBC Growth SPV 5, LLC.

• Board recommends voting FOR all proposals.

• Plurality required for director election; majority of votes cast required for other proposals.

• Abstentions and broker non-votes generally have no effect on outcomes.

Board of directors and corporate governance

• Board consists of nine members divided into three staggered classes, with directors serving three-year terms.

• Majority of directors are independent per Nasdaq standards; independent directors meet in executive session at least twice per year.

• Board leadership is separated, with an independent Chair and CEO roles.

• Compensation and Nominating Committee oversees director nominations and succession planning.